Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation

M Barber1, R C Tait, J Scott

  • 1University Section of Clinical Gerontology and Vascular Medicine and Department of Haematology, Royal Infirmary, Glasgow, UK. m.barber@clinmed.gla.ac.uk

Insights

Atrial fibrillation (AF) patients with dementia show higher levels of thrombin generation and fibrin turnover. Long-term warfarin use may offer protection against dementia development in AF patients.

Area of Science:

  • Cardiology
  • Neurology
  • Hematology

Background:

  • Atrial fibrillation (AF) is linked to cognitive decline and dementia.
  • This association may stem from a prothrombotic state and cardioembolism.
  • Investigating hemostatic alterations in AF with dementia is crucial.

Purpose of the Study:

  • To determine if hemostatic function differs in AF patients who develop dementia.
  • To assess if long-term warfarin anticoagulation protects against dementia in AF.
  • To explore the relationship between coagulation markers and cognitive decline in AF.

Main Methods:

  • Observational cohort study of atrial fibrillation (AF) patients.
  • Baseline measurements included plasma fibrinogen, D-dimer, prothrombin fragment 1+2 (F1+2), thrombin-antithrombin complexes (TAT), von Willebrand factor, and tissue plasminogen activator.
  • Cognitive function was assessed at 3 years using TICSm and IQCODE.

Main Results:

  • Higher D-dimer, F1+2, and TAT levels were observed in AF subjects with dementia.
  • These findings showed borderline statistical significance after age adjustment.
  • A trend suggested warfarin use was independently associated with reduced dementia prevalence (OR 0.52, P=0.08).

Conclusions:

  • Evidence indicates increased thrombin generation and fibrin turnover in AF patients with dementia.
  • Long-term warfarin therapy may be a protective factor against dementia in individuals with AF.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...